USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orpyx Medical Technologies Inc.

USPTO PatentsView assignee record - 21 granted patents across 20 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

21
Total patents granted
20
CPC technology areas
17.9
Avg claims per patent
+325%
5-year filing velocity

The verdict

Orpyx holds 21 US patents across 20 technology areas, rank #14,193 of 50,000 tracked assignees.

#14,193
of 50,000 US assignees by volume
Top 5%
by Innovation Score (57.3/100)
17.9
avg claims per patent
+325%
filing velocity, last 5 yrs

Portfolio overview

Orpyx Medical Technologies Inc. has been granted 21 US utility patents between 2015 and 2025, placing Orpyx Medical Technologies Inc. at rank #14,193 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Orpyx Medical Technologies Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Orpyx sits between Open Water Internet, Inc. (21 patents, rank #14,189) and PDSI (21 patents, rank #14,197) - the closest US assignees by grant volume. The composite Innovation Score of 57.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 4 in the 2015–2019 window, a +325% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Orpyx Medical Technologies Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Orpyx Medical Technologies Inc. against peers pursuing similar technology classes.

Who files at Orpyx's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Orpyx holds 21 patents at rank #14,193, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Orpyx

By rank, the assignees closest to #14,193 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Orpyx's primary technology class.

Orpyx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20152017201820212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Orpyx Medical Technologies Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 4.8%
2017 1 4.8%
2018 2 9.5%
2021 2 9.5%
2022 3 14.3%
2023 5 23.8%
2024 2 9.5%
2025 5 23.8%

Which technologies does Orpyx Medical Technologies Inc. patent most?

Top 15 of 20 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#14,193

Across all tracked assignees

Innovation Score

57.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Orpyx Medical Technologies Inc. hold?
Orpyx Medical Technologies Inc. holds 21 US granted patents filed between 2015 and 2025, spanning 20 technology areas.
What is Orpyx Medical Technologies Inc.'s Innovation Score?
Orpyx Medical Technologies Inc. has an Innovation Score of 57.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Orpyx Medical Technologies Inc. focus on?
Orpyx Medical Technologies Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 12 patents. The company has filed patents in 20 CPC subclasses total.
Is Orpyx Medical Technologies Inc.'s patent filing rate increasing or decreasing?
Orpyx Medical Technologies Inc.'s recent filing velocity is +325% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Orpyx Medical Technologies Inc.'s patents?
Orpyx Medical Technologies Inc.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Orpyx Medical Technologies Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Orpyx's 21 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Orpyx ranks #14,193 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.